Evidence map›Paper›PMID 36012474›Full record

ArticleInternational journal of molecular sciences2022

The Kinesin Gene

George A E Pickering, Favour Felix-Ilemhenbhio, Matthew J Clark, Klaudia Kocsy, Jonathan Simpson, Ilaria Bellantuono, Alison Gartland, Jeremy Mark Wilkinson, Konstantinos Hatzikotoulas, Endre Kiss-Toth

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

George A E PickeringDepartment of Oncology & Metabolism, University of Sheffield, Sheffield S10 2TN, UK.ORCID 0000-0002-2652-0288
Favour Felix-IlemhenbhioDepartment of Oncology & Metabolism, University of Sheffield, Sheffield S10 2TN, UK.ORCID 0000-0002-5371-5400
Matthew J ClarkDepartment of Oncology & Metabolism, University of Sheffield, Sheffield S10 2TN, UK.ORCID 0000-0003-2152-2257
Klaudia KocsyDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2TN, UK.ORCID 0000-0002-8007-8937
Jonathan SimpsonDepartment of Oncology & Metabolism, University of Sheffield, Sheffield S10 2TN, UK.
Ilaria BellantuonoDepartment of Oncology & Metabolism, University of Sheffield, Sheffield S10 2TN, UK.
Alison GartlandDepartment of Oncology & Metabolism, University of Sheffield, Sheffield S10 2TN, UK.
Jeremy Mark WilkinsonDepartment of Oncology & Metabolism, University of Sheffield, Sheffield S10 2TN, UK.ORCID 0000-0001-5577-3674
Konstantinos HatzikotoulasInstitute of Translational Genomics, Helmholtz Zentrum München-German Research Center for Health and the Environment, 85764 Neuherberg, Germany.
Endre Kiss-TothDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2TN, UK.ORCID 0000-0003-4406-4017
University of Sheffield · GBHelmholtz Zentrum München · DE

Funding

Medical Research Council MR/P020941/1National Institute for Health Research IS-BRC-1215-20017Versus Arthritis 21163
6 · The paper itself

Abstract

The formation of pathological bone deposits within soft tissues, termed heterotopic ossification (HO), is common after trauma. However, the severity of HO formation varies substantially between individuals, from relatively isolated small bone islands through to extensive soft tissue replacement by bone giving rise to debilitating symptoms. The aim of this study was to identify novel candidate therapeutic molecular targets for severe HO. We conducted a genome-wide scan in men and women with HO of varying severity following hip replacement for osteoarthritis. HO severity was dichotomized as mild or severe, and association analysis was performed with adjustment for age and sex. We next confirmed expression of the gene encoded by the lead signal in human bone and in primary human mesenchymal stem cells. We then examined the effect of gene knockout in a murine model of osseous trans-differentiation, and finally we explored transcription factor phosphorylation in key pathways perturbed by the gene. Ten independent signals were suggestively associated with HO severity, with

Indexed as

KinesinsOssification, HeterotopicOsteogenesisAnimalsCell DifferentiationFemaleHumansMaleMiceOsteocalcinRatsKIF26B protein, humanKinesinsOsteocalcinCRISPR-Cas9heterotopic ossificationKIF26Briskseverity

Identifiers

PMID36012474
PMCPMC9409126
OpenAlexW4292476266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.